10 X Genomics Inc (TXG)

Date: O: H: L: C: Vol:

Finanzdaten der 10 X Genomics Inc-Aktie (TXG)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.13%151.04	150.84	166.03	149.00	172.91
Cost Of Revenue	13.72%38.54	44.67	52.99	48.70	47.82
Gross Profit	5.95%112.50	106.18	113.05	100.31	125.08
	7.16%132.05	123.22	132.59	132.55	94.96
Selling, General, and Administrative	18.51%78.66	66.38	76.62	75.36	74.43
Operating Income/Loss	14.72%-19.56	-17.05	-19.54	-32.24	30.13
Nonoperating Income/Loss	78.33%0.91	4.20	4.35	4.04	6.87
Income/Loss From Continuing Operations Before Tax	45.13%-18.65	-12.85	-15.19	-28.21	37.00
Income Tax Expense/Benefit	214.61%-0.71	0.62	1.06	-0.73	2.46
	33.12%-17.93	-13.47	-16.25	-27.47	34.54
Attributable To Parent	33.12%-17.93	-13.47	-16.25	-27.47	34.54
Basic Average Shares	1.32%129.98	128.29	0.78	125.50	123.76
Diluted Average Shares	1.32%129.98	128.29	0.78	125.50	124.51
Basic Earnings Per Share	40.00%-0.14	-0.10	-0.13	-0.22	0.28
Diluted Earnings Per Share	40.00%-0.14	-0.10	-0.13	-0.22	0.28